$267.17
Danaher Corporation is a diagnostics & research business based in the US. Danaher Corporation shares (DHR) are listed on the NYSE and all prices are listed in US Dollars. Danaher Corporation employs 61,000 staff and has a trailing 12-month revenue of around $23.7 billion.
What's in this guide?
Our top picks for where to buy Danaher Corporation stock
How to buy Danaher Corporation stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – DHR. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Danaher Corporation stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Danaher Corporation stock price (NYSE: DHR)
Use our graph to track the performance of DHR stocks over time.Danaher Corporation shares at a glance
Latest market close | $250.89 |
---|---|
52-week range | $181.51 - $268.82 |
50-day moving average | $254.63 |
200-day moving average | $237.07 |
Wall St. target price | $272.04 |
PE ratio | 44.6044 |
Dividend yield | $1.05 (0.44%) |
Earnings per share (TTM) | $5.46 |
Is it a good time to buy Danaher Corporation stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Danaher Corporation price performance over time
Historical closes compared with the close of $250.89 from 2024-07-22
1 week (2024-07-16) | -0.50% |
---|---|
1 month (2024-06-21) | -1.60% |
3 months (2024-04-23) | -0.88% |
6 months (2024-01-23) | 8.10% |
1 year (2023-07-21) | -1.95% |
---|---|
2 years (2022-07-21) | -10.15% |
3 years (2021-07-23) | 291.27 |
5 years (2019-07-23) | 77.50% |
Is Danaher Corporation stock undervalued or overvalued?
Valuing Danaher Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Danaher Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Danaher Corporation's P/E ratio
Danaher Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 45x. In other words, Danaher Corporation shares trade at around 45x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Danaher Corporation's PEG ratio
Danaher Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.1267. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Danaher Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Danaher Corporation's EBITDA
Danaher Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $7.4 billion.
The EBITDA is a measure of a Danaher Corporation's overall financial performance and is widely used to measure a its profitability.
Danaher Corporation financials
Revenue TTM | $23.7 billion |
---|---|
Operating margin TTM | 23.09% |
Gross profit TTM | $18.9 billion |
Return on assets TTM | 3.86% |
Return on equity TTM | 7.76% |
Profit margin | 18.55% |
Book value | $72.16 |
Market Capitalization | $180.4 billion |
TTM: trailing 12 months
Danaher Corporation share dividends
Dividend payout ratio: 13% of net profits
Recently Danaher Corporation has paid out, on average, around 13% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.44% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Danaher Corporation shareholders could enjoy a 0.44% return on their shares, in the form of dividend payments. In Danaher Corporation's case, that would currently equate to about $1.05 per share.
While Danaher Corporation's payout ratio might seem low, this can signify that Danaher Corporation is investing more in its future growth.
Danaher Corporation's most recent dividend payout was on 25 July 2024. The latest dividend was paid out to all shareholders who bought their shares by 27 June 2024 (the "ex-dividend date").
Have Danaher Corporation's shares ever split?
Danaher Corporation's shares were split on a 1128:1000 basis on 1 October 2023. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1128 shares. This wouldn't directly have changed the overall worth of your Danaher Corporation shares – just the quantity. However, indirectly, the new 11.3% lower share price could have impacted the market appetite for Danaher Corporation shares which in turn could have impacted Danaher Corporation's share price.
Danaher Corporation share price volatility
Over the last 12 months, Danaher Corporation's shares have ranged in value from as little as $181.5098 up to $268.8214. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Danaher Corporation's is 0.861. This would suggest that Danaher Corporation's shares are less volatile than average (for this exchange).
Danaher Corporation overview
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company has a research collaboration with Stanford University's Department of Bioengineering for cancer drug development. The company was formerly known as Diversified Mortgage Investors, Inc.
Frequently asked questions
nullWhat percentage of Danaher Corporation is owned by insiders or institutions?
Currently 10.727% of Danaher Corporation shares are held by insiders and 81.563% by institutions. How many people work for Danaher Corporation?
Latest data suggests 61,000 work at Danaher Corporation. When does the fiscal year end for Danaher Corporation?
Danaher Corporation's fiscal year ends in December. Where is Danaher Corporation based?
Danaher Corporation's address is: 2200 Pennsylvania Avenue, North West, Washington, DC, United States, 20037-1701 What is Danaher Corporation's ISIN number?
Danaher Corporation's international securities identification number is: US2358511028 What is Danaher Corporation's CUSIP number?
Danaher Corporation's Committee on Uniform Securities Identification Procedures number is: 235851110
More guides on Finder
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
Put options explained
Learn the basics of put options: what they are, how they work and a few examples.
-
Frec review 2024: Low-cost direct indexing and individual stock trading
A deep dive into the highlights and limitations of Frec.
-
7 best day trading platforms of July 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
11 apps like Webull you need to consider
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
-
5 top graphene stocks to invest in today
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question